NCT00037531View on ClinicalTrials.gov

Study Evaluating Sirolimus (Rapamune™) in Solid Organ Transplant Recipients

PHASE3CompletedINTERVENTIONAL
Enrollment

769

Participants

Timeline

Start Date

Not specified

Primary Completion Date

August 31, 2004

Study Completion Date

August 31, 2004

Conditions
Graft vs Host DiseaseKidney Transplantation
Interventions
DRUG

Sirolimus (RAPAMUNE)

Trial Locations (20)

10029

New York

15213

Pittsburgh

19141

Philadelphia

28232

Charlotte

30322

Atlanta

30912

Augusta

33606

Tampa

60637

Chicago

90057

Los Angeles

92123

San Diego

94304

Stanford

90095-1752

Los Angeles

46202-5250

Indianapolis

29425-0777

Charleston

T6G 2B7

Edmonton

V5Z 1M9

Vancouver

B3H 2Y9

Halifax

M5B 1W8

Toronto

M5G 2C4

Toronto

H2L 2W5

Montreal

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY